Avidity Biosciences, Inc. (RNA) Reports Q2 Loss, Misses Revenue Estimates

Avidity Biosciences, Inc. (RNA) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of$ 0.76. This compares to loss of $0.66 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 14.47%. A quarter ago, it was expected that this company would post a loss of$ 0.81 per share when it actually produced a loss of $0.79, delivering a surprise of 2.47%. Over the last four quarters, the company ha ...